Modified Release
Modified release formulation development and manufacturing are notoriously challenging. Recro has the experience and organizational know-how to get your oral solid dosage product right.
Pioneering modified release since the 1980s at one of the first U.S. sites to apply this technology, our scientists have decades of experience in the field. With an extensive history of manufacturing modified release dosage forms, our development and commercial teams are ready to leverage their keen insights and offer solutions to advance your project.
With right-sized, proactive management, a proven track record of tackling the most complex formulations, and unparalleled regulatory expertise, our specialists will collaborate with you from concept to commercialization — and at every milestone in between — to deliver a modified release formulation and process that exceed your expectations.
Commercially Manufactured Drugs That Are Modified Release
Recro Formulators With a Ph.D.
Combined Development Experience
Partner with us for modified release development and manufacturing to benefit from:
A Legacy of Experience

Master Formulators

Company-Wide Focus On Modified Release

Concept to Commercialization

Culture of Collaboration

Unparalleled Regulatory Support

Have a project in mind? Recro is your go-to for modified release.
Modified Release Resources
How to Achieve Different Release Profiles and Select Excipients for Formulation Development of Modified Release Oral Solid Dosage Forms
In pharmaceutical manufacturing, the formulation and manufacture of modified release oral solid dosage forms is highly specialized. To obtain the desired release profile(s), a holistic approach is necessary. This paper details numerous considerations for the planning and execution of a successful modified release oral solid dosage formulation.
Is Wurster Processing the Right Choice for My Multiparticulate Modified Release Dosage Form?
Wurster processing is an extremely versatile pharmaceutical development and manufacturing technique for multiparticulates to be used in modified release (e.g., extended or controlled release) dosage forms. How do you know if it’s the right method for your modified release project?